Search results
Emcure Pharma IPO: Issue fully subscribed on day 1; check subscription status, GMP and other details...
Livemint· 4 days agoBefore the issue opened, the company secured ₹582 crore from anchor investors. Notable participants...
Sankha Bhowmick joins WhiteOak Capital Management as CHRO - ETHRWorld
The Economic Times· 3 days agoBefore joining WhiteOak Capital, Bhowmick was working with Goldman Sachs where he was responsible...
Indian-American Man's Rs 8,300 Crore Fraud Scheme Shakes Top US Investors
NDTV· 5 days agoThe saga involves a Rs 8,300 crore ($1 billion) fraud scheme that shook high-profile investors like ...
Ad-scam, lavish lies, and a billion-dollar fraud: How Rishi Shah’s Outcome Health duped high-profile...
Financial Express· 4 days agoThis high-profile case, reported by the Wall Street Journal, has drawn significant attention due to...
OpenAI Reaffirms Support To India's AI Missions
Free Press Journal· 4 days agoOpen AI Vice President Srinivas Narayanan said on Wednesday that his company, which runs ChatGPT, will support the AI missions and application...
Restaurants Brand Asia stock rallies 5% after HDFC Mutual Fund buys stake
Business Standard India· 2 days agoShares of Restaurants Brand Asia soared up to 5 per cent at 113.92 per share on the BSE in Friday's...
WhiteOak Capital Management appoints Sankha Bhowmick as CHRO
CNBC Awaaz· 4 days agoWhiteOak Capital Management on July 3 announced the appointment of Sankha Bhowmick as its chief...
Purplle bags Rs 1,000 crore led by ADIA - Times of India
The Times of India· 5 days agoThe funding which is a mix of primary and secondary investment values the omni-channel beauty retailer at about $1.3 billion, sources said. As part of the secondary transaction, Purplle’s existing ...
Emcure Pharma IPO Soars: Oversubscribed 66 Times on Day 3 | India Infoline
India Infoline· 1 day agoThe categories earmarked for NII and QIB investors received the most subscriptions, at 47.98 and 193.06 times, respectively.
Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid? - The Economic Times
The Economic Times· 4 days agoEmcure Pharmaceuticals IPO, with marquee investors like Goldman Sachs, offers a fresh equity...